Italy · Delayed Price · Currency is EUR AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of EUR 330.35 billion. The enterprise value is 383.48 billion.
| Market Cap | 330.35B |
| Enterprise Value | 383.48B |
Important Dates
The last earnings date was Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Jan 15, 2026 |
Share Statistics
| Current Share Class | 1.77B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 74.04% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 91.78 and the forward PE ratio is 15.18.
| PE Ratio | 91.78 |
| Forward PE | 15.18 |
| PS Ratio | 6.34 |
| PB Ratio | -149.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 106.54 |
| EV / Sales | 7.46 |
| EV / EBITDA | 15.51 |
| EV / EBIT | 21.51 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.34 |
| Debt / FCF | n/a |
| Interest Coverage | 8.08 |
Financial Efficiency
Return on equity (ROE) is 1,106.67% and return on invested capital (ROIC) is 22.47%.
| Return on Equity (ROE) | 1,106.67% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.47% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 947,090 |
| Profits Per Employee | 65,442 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 2.01 billion in taxes.
| Income Tax | 2.01B |
| Effective Tax Rate | 35.83% |
Stock Price Statistics
The stock price has increased by +2.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.11% |
| 50-Day Moving Average | 190.28 |
| 200-Day Moving Average | 180.43 |
| Relative Strength Index (RSI) | 51.82 |
| Average Volume (20 Days) | 49 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.05 |
Income Statement
In the last 12 months, AbbVie had revenue of EUR 52.09 billion and earned 3.60 billion in profits. Earnings per share was 2.01.
| Revenue | 52.09B |
| Gross Profit | 37.32B |
| Operating Income | 18.07B |
| Pretax Income | 5.62B |
| Net Income | 3.60B |
| EBITDA | 25.05B |
| EBIT | 18.07B |
| Earnings Per Share (EPS) | 2.01 |
Balance Sheet
The company has 4.83 billion in cash and 58.64 billion in debt, with a net cash position of -53.81 billion.
| Cash & Cash Equivalents | 4.83B |
| Total Debt | 58.64B |
| Net Cash | -53.81B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.21B |
| Book Value Per Share | -1.27 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.64%, with operating and profit margins of 34.69% and 6.91%.
| Gross Margin | 71.64% |
| Operating Margin | 34.69% |
| Pretax Margin | 10.79% |
| Profit Margin | 6.91% |
| EBITDA Margin | 48.10% |
| EBIT Margin | 34.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.75, which amounts to a dividend yield of 3.04%.
| Dividend Per Share | 5.75 |
| Dividend Yield | 3.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 2.81% |
| Earnings Yield | 1.09% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |